Cipher Pharmaceuticals, Inc.

Cipher Pharmaceuticals Inc. is a specialty pharmaceutical company actively engaged in the development, acquisition, and commercial licensing of dermatology-focused products. This Canadian-based company is committed to advancing dermatological therapies that address unmet medical needs, offering a portfolio that includes prescription products for conditions such as acne, actinic keratosis, and plaque psoriasis. Cipher Pharmaceuticals' strategic approach involves forming partnerships to enhance its array of therapeutic solutions while ensuring broad market access across North America and other global regions. By focusing on dermatological indications, the company plays a pivotal role in a niche yet vital segment of the pharmaceutical industry, aiming to deliver innovative solutions that enhance the quality of life for patients. With its focus on research and commercial execution, Cipher Pharmaceuticals remains a notable entity contributing to the dermatological pharmaceutical landscape, distinguished by its targeted approach to product development and market expansion.